Clinical trial
Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis
NCT02842424 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis
- Lead sponsor
- University of Nebraska
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- February 25, 2016
- Completion date
- June 30, 2026
- Enrollment
- 70 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.